New drugs for methicillin-resistant Staphylococcus aureus: an update

dc.contributor.author	Kumar, Krishna
dc.contributor.author	Chopra, Sidharth
dc.date.accessioned	2014-04-02T11:25:20Z
dc.date.available	2014-04-02T11:25:20Z
dc.date.issued	2013
dc.identifier.citation	Journal of Antimicrobial Chemotherapy, 2013, 68 (7): 1465-1470.	en
dc.identifier.uri	http://hdl.handle.net/123456789/1196
dc.description.abstract	Methicillin-resistant S. aureus (MRSA) remains the leading cause of bacterial infections worldwide with a dwindling repertoire of effective antimicrobials active against it. This review aims to provide an update on novel anti-MRSA molecules currently under pre-clinical and clinical development with emphasis on their mechanism of action. This review is limited to molecules that target the pathogen directly and does not detail immunomodulatory anti-infectives.	en
dc.format.extent	103278 bytes
dc.format.mimetype	application/pdf
dc.language.iso	en	en
dc.relation.ispartofseries	CSIR-CDRI Communication No. 8388	en
dc.subject	MRSA	en
dc.subject	Antibiotics	en
dc.subject	Mechanism of Action	en
dc.title	New drugs for methicillin-resistant Staphylococcus aureus: an update	en
dc.type	Article	en